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Acinetobacter baumannii is a major nosocomial pathogen causing human infections
with significant mortality rates. In most cases, infections are acquired through exposure
to A. baumannii biofilms that persist on contaminated hospital equipment and surfaces.
Thus, it is imperative to develop effective measures for controlling A. baumannii biofilms
in nosocomial settings. This study investigated the efficacy of octenidine dihydrochloride
(OH), a new generation disinfectant for reducing A. baumannii biofilms on polystyrene,
stainless steel and catheters. OH at 0.3% (5 mM), 0.6% (10 mM), and 0.9% (15 mM)
was effective in significantly inactivating A. baumannii biofilms on all tested surfaces
(P < 0.05). Furthermore, OH was equally effective in inactivating biofilms of multidrug
resistant and drug susceptible A. baumannii isolates. In addition, confocal imaging
revealed the predominance of dead cells in the OH-treated samples in comparison
to the control. Further, scanning electron microscopy of biofilms formed on catheters
revealed that OH treatment significantly reduced A. baumannii biofilm populations in
corroboration with our antibiofilm assay. These data underscore the efficacy of OH in
inactivating A. baumannii biofilms, thereby suggesting its potential use as a disinfectant
or a catheter lock solution to control A. baumannii infections.
Keywords: Acinetobacter baumannii, nosocomial infections, biofilm, octenidine dihydrochloride, stainless steel,
urinary catheter
INTRODUCTION
Acinetobacter baumannii is a Gram-negative opportunistic pathogen commonly associated with
nosocomial infections (Peleg et al., 2008), including pneumonia, septicemia, wound infection,
urinary tract infection, endocarditis, meningitis, blood stream infections, osteomyelitis, and
corneal perforation (Bergogne-Bérézin and Towner, 1996; Ribera et al., 2003; Briggs et al., 2004;
Dijkshoorn et al., 2007; Federico et al., 2011). It is ranked as one of the most common bacteria
linked to infections associated with intensive care units (Giamarellou, 2010; Medell et al., 2013).
A. baumannii has been identified as a “red alert” human pathogen, generating alarm among
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medical practitioners due to its extensive antibiotic resistance
spectrum (Maragakis and Perl, 2008; Neonakis et al., 2011;
Howard et al., 2012). The Infectious Diseases Society of America
ranked A. baumannii as a top priority, antibiotic-resistant
pathogens to target because of its rapid tendency to develop
drug resistance, and the availability of a narrow choice of
antibiotics to treat infections caused by the bacterium (Talbot
et al., 2006).
Besides antibiotic resistance, a major concern with
A. baumannii is its ability to form biofilms (Longo et al.,
2014). Biofilms are surface-associated bacterial conglomerates
that enable bacteria to survive and persist on abiotic surfaces
for long periods of time while being resistant to commonly
used antibiotics and disinfectants (Sambanthamoorthy et al.,
2014). Several studies have demonstrated that biofilm formation
permits the survival and persistence of A. baumannii on abiotic
hospital surfaces resulting in tenacious and recurring nosocomial
infections (Orsinger-Jacobsen et al., 2013; Longo et al., 2014;
Sambanthamoorthy et al., 2014). Several antimicrobial
candidates have been evaluated for their antibiofilm activity
against A. baumannii in vitro and in vivo. These include
antibiotics (Jamal et al., 2014; Wang et al., 2014), quorum
sensing inhibitors, including lactonases and c-di-GMP inhibitors
(Chow et al., 2014; Sambanthamoorthy et al., 2014), chimeric
antimicrobial peptides (Gopal et al., 2014), antibiofilm peptides
(Reffuveille et al., 2014), antimicrobial based wound gels
(Gawande et al., 2014), disinfectants such as chlorhexidine, Lysol
and bleach (Orsinger-Jacobsen et al., 2013) and other compounds
like Virstatin, cerium, chitosan, and hamamelitannin (Cobrado
et al., 2013; Chabane et al., 2014). Although these approaches
have shown promise in the control of Acinetobacter biofilms,
most have been investigated for application to prevent wound
infections. However, it is well established that biofilm formation
on abiotic surfaces such as medical devices plays a crucial role in
the transmission of A. baumannii in nosocomial settings (Gaddy
and Actis, 2009; McConnell et al., 2013). Therefore, besides
controlling Acinetobacter associated pathologies, elimination
of the pathogen from the hospital environment is equally
critical to preventing A. baumannii infections in humans.
Successful eradication of the pathogen from the nosocomial
environment entitles the complete killing (inactivation) of the
biofilm associated bacterial cells thereby rendering the biofilm
dead and non-infectious.
Octenidine dihydrochloride (OH) is a positively charged
bispyridinamine exhibiting antimicrobial activity against plaque-
producing bacteria such as Streptococcus mutans and S. sanguis
(Bailey et al., 1984). Recent studies have also demonstrated
its antimicrobial efficacy against Escherichia coli O157:H7 (OH
@ 0.15 and 0.25%), Staphylococcus aureus, Methicillin-resistant
and Vancomycin-resistant S. aureus (MRSA, VRSA; OH @
0.15, 0.3 and 0.6%), Salmonella Enteritidis (OH @ 0.15 and
0.25%), Enterococcus faecalis (OH @ 0.1%), Candida albicans
(OH @ 0.1%) Listeria monocytogenes (OH @ 0.15 and 0.25%)
and Pseudomonas aeruginosa (OH @ 0.1%; Zumbotel et al.,
2009; Tirali et al., 2010; Baskaran et al., 2012; Amalaradjou
and Venkitanarayanan, 2014; Junka et al., 2014; Makkar et al.,
2015). OH was found to possess high tissue tolerability, and
hence has been applied topically to prevent open wound
infections (Hubner et al., 2010; Vanscheidt et al., 2012). Selcuk
et al. (2012) demonstrated the antimicrobial efficacy of OH
against A. baumannii in a mouse burn model, where they
observed that wound treatment with octenisept (Schülke & Mayr
GmBH, Norderstedt, Germany; active ingredient – 0.1% OH)
significantly reduced A. baumannii populations in the eschar
tissue compared to commonly used wound treatments such
as silver sulfadiazine and mupirocin. Besides its antimicrobial
effect, toxicity studies in a variety of species indicated
that OH is not absorbed through the mucous membrane
and gastrointestinal tract, with no reported carcinogenicity,
genotoxicity or mutagenicity (Hirsch et al., 2009). However,
no studies have investigated the antibiofilm effect of OH on
A. baumannii, especially on surfaces commonly encountered in
hospital settings. Therefore this study determined the efficacy of
OH (0.3, 0.6, and 0.9%) to inactivate A. baumannii biofilms on
polystyrene, stainless steel and urinary catheters.
MATERIALS AND METHODS
Culture Preparation
All bacteriological media were purchased from Difco (Becton
Dickinson, Sparks, MD, USA). The antibiofilm effect of OH
was investigated using two A. baumannii isolates, namely
A. baumannii ATCC 17978 (drug susceptible brain isolate,
American Type Culture Collection, Manassas, VA, USA; Adams
et al., 2009) and A. baumannii 190451 (multidrug resistant
respiratory tract isolate, International health management
associates, Schaumburg, IL, USA). The antibiotic resistance
profile of A. baumannii 190451 was amikacin (MIC 64 µg/mL),
amoxicillin (MIC 32 µg/mL), cefepime (MIC 32 µg/mL),
ceftazidime (MIC 32 µg/mL), ceftriaxone (MIC 64 µg/mL),
imipenem (MIC 4–32 µg/mL), levofloxacin (MIC 8 µg/mL),
meropenem (MIC 16 µg/mL), minocycline (MIC 1–16 µg/mL),
and piperacillin (MIC 128 µg/mL; Karumathil et al., 2014).
Stock cultures were stored at −80◦C in tryptic soy broth (TSB)
with 50% glycerol. Prior to each experiment, each isolate of
A. baumannii was grown individually on MDR Acinetobacter
agar (Hardy Diagnostics, Santa Maria, CA, USA), and an
individual colony from this medium was sub cultured at least
three times in TSB for 24 h at 37◦C with shaking (200 rpm). After
the subcultures, bacterial cells were harvested from an overnight
culture by centrifugation at 3,600× g for 30 min at 4◦C. The cells
were washed twice in sterile phosphate buffered saline (PBS; 1x
PBS pH 7.2 consisting of 137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, and 2 mM KH2PO4), and the bacterial cell pellet was
finally resuspended in PBS, which was used as the inoculum. The
bacterial population in the inoculum was confirmed by broth
dilution and surface plating on tryptic soy agar (TSA) plates and
incubation at 37◦C for 24 h (Karumathil et al., 2014).
Octenidine Dihydrochloride
Octenidine dihydrochloride (>99%) was obtained from Dishman
USA, Middlesex, NJ, USA.
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Inactivation of A. baumannii Biofilms on
Polystyrene by OH
The antibiofilm effect of OH was determined by microtiter plate
assay (Amalaradjou et al., 2010). Briefly, A. baumannii cultures
were separately grown overnight in TSB at 37◦C. Following
incubation, the cultures were sedimented by centrifugation
(3,600 × g for 15 min), washed twice with PBS and resuspended
in 10 mL of TSB. Two hundred microliters of the washed
culture was used as the inoculum (∼6.0 log CFU). Sterile 96-well
polystyrene tissue culture plates (Costar, Corning Incorporated,
Corning, NY, USA) were inoculated with 200µL of each bacterial
cell suspension (∼6.0 log CFU) and incubated at 37◦C for
24 h without agitation for biofilm production. Following biofilm
formation, the effect of OH was tested at 0 (negative control),
0.3% (5 mM), 0.6% (10 mM), and 0.9% (15 mM) with an exposure
time of 0, 1, 5, and 10 min. Since ethanol is a common disinfectant
used in hospital settings and was used as the solvent for OH, all
experiments also included samples that were treated with ethanol
as a solvent control. After exposure to OH for the specified time,
wells were washed three times with 200 µL of sterile PBS, and
the adherent biofilm was scraped and plated directly or after
serial dilution in PBS on TSA plates. The plates were incubated
at 37◦C for 24 h before enumerating biofilm-associated bacterial
population. Duplicate wells were included for each treatment,
and the assay was repeated three times.
Biofilm Assay on Stainless Steel Matrix
Stainless steel (type 304 with a 4b finish) was used for making
coupons (diameter: 1 cm). Stainless steel coupons were washed
and cleaned prior to use, as described by Amalaradjou et al.
(2009). A. baumannii cells were grown in TSB and diluted 1:40,
as described before (Amalaradjou et al., 2009). Two hundred
microliters of the inoculum were then dispensed onto the
stainless steel coupons submerged in a 24-well plate (Becton
Dickson Labware, Franklin Lakes, NJ, USA). Biofilm was formed
at 37◦C as before, and treated with 70% ethanol (solvent control),
0 (negative control), 0.3% (5 mM), 0.6% (10 mM), and 0.9%
(15 mM) OH for 0, 1, 5, or 10 min. Following this, biofilm-
associated A. baumannii cells were dispersed and enumerated
(Ayebah et al., 2005). Duplicate coupons were included for each
treatment, and the experiment was replicated three times.
Biofilm Assay on Urinary Catheters
The efficacy of OH as a catheter lock solution ingredient in
inactivating A. baumannii biofilms on catheters was determined
according to a previously described protocol (Amalaradjou et al.,
2010). A 12 F Foley urinary tract catheter (At Home Medical)
was cut into 3-cm pieces. Each catheter piece was sealed at one
end, filled with 1 mL of bacterial culture (∼6.0 log CFU) and
sealed at the other end. The catheter pieces were then incubated
at 37◦C for 5 days to facilitate biofilm formation on the catheter
lumen surface. After 5 days, each catheter piece was washed with
sterile saline to remove unattached cells, sealed at one end, filled
with 1 mL of sterile normal saline (negative control) or saline
containing 70% ethanol (solvent control), 0.3% (5 mM), 0.6%
(10 mM), and 0.9% (15 mM)OH, sealed at the other end and
incubated at 37◦C. The biofilm-associated bacterial population
was determined following OH exposure (0, 15, 30, and 60 min)
by enumerating bacteria after dislodging the biofilm from the
catheter surface. This was achieved by vortexing the catheter
pieces in separate tubes containing 10 mL of PBS for 1 min,
followed by sonication at 40 KHz for 5 min in a bath sonicator
(Branson, North Olmstead, OH, USA). After sonication, viable
bacterial counts in PBS from each tube were enumerated after
serial dilution (1:10 in PBS) and plating on duplicate TSA plates.
Two catheter pieces were included for each treatment, and the
experiment was repeated three times. In all the experiments, the
antibiofilm effect of OH was also evaluated in the presence of
serum albumin to simulate the presence of organic contaminants
on hospital contact surfaces (Edmiston et al., 2006).
Confocal Microscopy
In situ confocal laser scanning microscopy was done to visualize
the efficacy of OH in inactivating A. baumannii biofilms
(Amalaradjou and Venkitanarayanan, 2014). For microscopic
assessment, A. baumannii biofilms were grown on Lab-Tech
four-chamber borosilicate glass coverslip (Lab-tek, Nalge Nunc
International, Rochester, NY, USA) at 37◦C in TSB for 24 h. The
microscopy was performed according to the method reported by
Amalaradjou and Venkitanarayanan (2014). Briefly, preformed
biofilms were treated with 0.6% (10 mM) OH for 60 min and
the live and dead cells were imaged after staining with 2.5 µM
SYTO (Molecular probes, OR) and 5 µM propidium iodide
(PI, Molecular probes, OR). Biofilms not treated with OH were
imaged to view the normal architecture of A. baumannii biofilm.
Samples were examined under a Leica true confocal scanner
SP2 microscope using the water immersion lens. A krypton-
argon mixed gas laser with PMT2 filter served as the excitation
source.
FIGURE 1 | Inactivation of Acinetobacter baumannii ATCC 17978 (Ab
17978) and A. baumannii 190451 (Ab 190451) biofilm on polystyrene by
octenidine hydrochloride. Duplicate samples were used for each treatment,
and the experiment was replicated three times. Data are represented as
mean ± SEM.
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FIGURE 2 | Inactivation of A. baumannii ATCC 17978 (Ab 17978) and
A. baumannii 190451 (Ab 190451) biofilm on stainless steel by
octenidine hydrochloride. Duplicate samples were used for each treatment,
and the experiment was replicated three times. Data are represented as
mean ± SEM.
FIGURE 3 | Inactivation of A. baumannii ATCC 17978 (Ab 17978) and
A. baumannii 190451 (Ab 190451) biofilm in urinary catheters by
octenidine hydrochloride. Duplicate samples were used for each treatment,
and the experiment was replicated three times. Data are represented as
mean ± SEM.
Scanning Electron Microscopy (SEM)
Acinetobacter baumannii ATCC 17978 biofilm formation and
inactivation by OH on stainless steel coupons and urinary
catheters was examined by SEM (Djeribi et al., 2012).
A. baumannii biofilms were formed on stainless steel coupons
and catheter pieces as described previously. Following biofilm
formation, the inoculated catheter pieces and coupons were
washed with sterile PBS to dislodge the loosely attached and
unattached bacterial cells. Subsequently, they were treated with
either 0.6% (10 mM) OH or sterile PBS for 15 min at 37◦C.
Samples were then fixed in glutaraldehyde-paraformaldehyde-
cacodylate buffer (pH 7) at 4◦C for 90 min. Following fixation,
catheters were washed with 0.1 M Na cacodylate buffer (pH 7)
and post-fixed in 1% osmium tetroxide at 4◦C overnight. The
catheters were then rinsed twice for 15 min in distilled water,
then dehydrated in serial concentrations of ethanol (30, 50, 70,
95, 100, and 100% ETOH, 15 min each), and critical point
dried (931GL, Tousimis). The dried catheter samples were then
mounted on SEM stub using silver paint and sputter coated with
gold/palladium (E5100, Polaron) and examined using a scanning
electron microscope (FEI Nova Nano SEM 450).
Statistical Analysis
Duplicate samples were used for each treatment, and each
experiment was replicated three times. For each treatment
and control, data from independent replicate trials were
pooled and analyzed using the proc GLM sub-routine of the
statistical analysis software. The model included the treatment
concentrations and time as the major effects. A least significant
difference test was used to determine significant differences
(p< 0.05) due to treatment concentrations and time on bacterial
counts.
RESULTS AND DISCUSSION
The high nosocomial incidence of A. baumannii in endemic
and epidemic situations can be attributed to their resistance
to antibiotics and ability to form biofilms on hospital surfaces
and medical devices (de Breij et al., 2010). Biofilm formation
enhances A. baumannii colonization and persistence in the
hospital environment, which in turn increases the likelihood of
nosocomial infections (Espinal et al., 2012). Additionally, it has
been demonstrated that biofilm formation on abiotic surfaces is
a characteristic feature of clinical A. baumannii strains isolated
from bloodstream infections and catheter-associated urinary
tract infections (CAUTI, Feng et al., 2013). Therefore eradication
of environmental sources of A. baumannii is critical to the
prevention of nosocomial infections caused by this pathogen.
Previously, Amalaradjou and Venkitanarayanan (2014)
demonstrated the rapid antibiofilm effect of OH against other
antibiotic resistant nosocomial pathogens, namely Methicillin-
resistant and Vancomycin-resistant S. aureus. The present study
investigated the antibiofilm efficacy of OH against A. baumannii,
where the results indicated that OH was effective in rapidly
inactivating A. baumannii biofilm on all three matrices, namely
polystyrene, stainless steel and urinary catheters in the presence
and absence of serum protein. OH was equally effective against
A. baumannii ATCC 17198 (drug susceptible strain) and 190451
(multidrug resistant strain) biofilms. Further, OH retained its
antibiofilm efficacy and resulted in a similar inactivation of the
biofilm on all matrices, as observed in the absence of protein
(data not shown). The effect of OH on Acinetobacter biofilms
on microtiter plates is shown in Figure 1. The treatment of
polystyrene surface with 0.6% (10 mM) and 0.9% (15 mM)
OH resulted in a reduction in biofilm associated A. baumannii
population by greater than 5 log CFU/well after 10 and 5 min
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of exposure, respectively. However, control and ethanol had no
significant effect on the biofilm population (P > 0.05).
Since A. baumannii is capable of forming biofilms on abiotic
surfaces such as hospital environments, including stainless
implants (Orsinger-Jacobsen et al., 2013), we investigated the
antibiofilm effect of OH on stainless steel matrix. It can be
observed from Figure 2 that 0.6% (10 mM) and 0.9% (15 mM)
OH decreased A. baumannii biofilm to undetectable levels by 10
and 5 min, respectively. A concentration dependent antibiofilm
effect was observed with 0.9% (15 mM) OH being more effective
than 0.6% (10 mM) and 0.3% (5 mM) OH (P< 0.05). As observed
with the microtiter assay, the use of ethanol did not exert any
antibiofilm effect, with∼6 log CFU/coupon of biofilm associated
bacteria recovered at the end of the study.
In addition to wound infections, A. baumannii has been
implicated in medical device associated infections, particularly
TABLE 1 | Antimicrobial efficacy of octenidine hydrochloride against Acinetobacter baumannii biofilm in comparison to commonly used disinfectants.
Disinfectant Concentration Matrix Log reduction in biofilm
population (log CFU)
Time required for
log reduction (min)
Reference
Alkyl dimethyl ammonium
chloride (Lysol)
37.5% Stainless steel No reduction observed ≥20 Orsinger-Jacobsen
et al., 2013
Hydrogen peroxide 6.25% Stainless steel No reduction observed ≥20 Orsinger-Jacobsen
et al., 2013
Hypochlorite 3.125% Stainless steel ≥5 ≥1 Orsinger-Jacobsen
et al., 2013
Quaternary ammonium
compounds
15% Polystyrene No log reduction observed ≥60 Ramos and Alonso,
2013
Octenidine hydrochloride 0.9 % Polystyrene
Stainless steel
Foley’s catheter
≥6
≥6
≥6
5–10
5–10
30–60
This study
Ethanol 70% Polystyrene
Stainless steel
Foley’s catheter
No reduction
Observed on all
Matrices tested
≥10
≥10
≥60
This study
FIGURE 4 | Confocal microscopy of A. baumannii ATCC 17978 biofilm without treatment (A) and after treatment with octenidine hydrochloride (B).
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FIGURE 5 | Ultrastructural images of A. baumannii ATCC 17978 biofilm on stainless steel coupons and urinary catheters. (A) Coupons without
treatment, (B) coupons after OH treatment, (C) catheter without treatment, and (D) catheter after OH treatment. Arrows indicate A. baumannii cells on the catheter
surface.
those involving indwelling urinary catheters and central venous
catheters (Djeribi et al., 2012; Cobrado et al., 2013). Bacterial
biofilms can colonize the inner surface of indwelling urinary
catheters and lead to CAUTIs (Djeribi et al., 2012). These biofilms
pose a significant threat to patients who have an imperative need
for indwelling medical devices. It also makes treatment difficult
and in some cases ineffective due to the continuous presence
of planktonic bacteria that result from biofilm formation and
shedding (Djeribi et al., 2012). Several preventive measures
and treatment strategies have been explored to control catheter
related infections, including catheter antimicrobial coating (Saint
et al., 2000; Jamal et al., 2014), insertion site disinfection (Maki
et al., 1991) and antimicrobial catheter lock solution (Shah
et al., 2002). A few approaches have had some success, but
CAUTI remains a concern worldwide, highlighting the necessity
for effective approaches to control A. baumannii associated
CAUTI. These approaches should be safe and capable of rapidly
inactivating existing biofilms on catheters.
Besides inactivating Acinetobacter biofilms on polystyrene
and stainless steel matrix, OH was effective in eliminating
biofilms formed on urinary catheters. As a catheter lock
solution constituent, 0.6% (10 mM) and 0.9% (15 mM) OH
completely inactivated A. baumannii biofilms by 60 and 30 min
of treatment, respectively (Figure 3). Treatment of catheters
with 0.9% (15 mM) OH reduced the biofilm population by
3 log CFU/catheter piece almost immediately after exposure,
with complete inactivation observed at 30 min. Biofilm counts
on control catheters remained ∼6.0 log CFU/catheter piece
throughout the experiment. However, all OH concentrations
significantly reduced biofilm population to below detection levels
by 60 min of exposure. These results indicate that OH is more
effective in inactivating A. baumannii biofilm in comparison to
ethanol (70%), a commonly used disinfectant.
In addition to ethanol, hospitals may also employ Lysol
(Alkyl dimethyl ammonium chloride), hydrogen peroxide and
hypochlorite (household bleach). Orsinger-Jacobsen et al. (2013)
evaluated the efficacy of commonly used hospital disinfectants
(Lysol, ethanol, hydrogen peroxide, and hypochlorite) on their
ability to inhibit A. baumannii biofilms on stainless steel. They
observed that all of the tested strains were 100% susceptible to
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3.125% hypochlorite, with complete inactivation of the biofilm
after 1 min of exposure. However, in the present study we
observed that OH at much lower concentration (0.9%) could
rapidly inactivate A. baumannii biofilm not only on stainless
steel but also on polystyrene and urinary catheters. Table 1
summarizes the anti-biofilm efficacy of OH against A. baumannii
in comparison with other disinfectants.
To investigate the effect of OH on biofilm structure,
A. baumannii biofilms formed on glass coverslips were analyzed
by confocal microscopy. Positive staining using SYTO and
Propidium iodide (PI) was used for imaging the biofilms. The
confocal images of the negative control samples (Figure 4A)
with no added OH revealed the formation of a dense biofilm
viewed as green cells (live) stained by the SYTO dye, while
the image of OH-treated samples (Figure 4B) revealed the
presence of orange-red cells (stained by PI) indicating the
biofilm is composed of dead and dying cells as opposed to
the control. Although the biofilm was uniformly distributed
over the imaged surface, analysis for % live-dead using ImageJ
(Rasband, 1997–2015) revealed that 92% of the biofilm in the
OH-treated sample was comprised of dead, non-viable cells as
opposed to 100% live in the control. Furthermore, in order
to visualize the morphology and ultrastructural features of
A. baumannii biofilms on stainless steel and catheters, SEM
was performed. The SEM images of A. baumannii biofilm
grown on stainless steel coupons and urinary catheters are
depicted in Figure 5. These images confirm the presence of
biofilm growth on the coupons (Figure 5A) and catheter pieces
(Figure 5C), where the biofilm is visible as a monolayer of
individual cells scattered over the matrix surface (Figure 5). In
addition, analysis of the cross-section and inner surface of the
catheter samples revealed that the relative number of bacteria
attached to the catheter pieces treated with OH was significantly
less compared to the untreated samples (Figure 5D). A similar
reduction in bacterial population was also observed in the OH-
treated coupons (Figure 5B). Furthermore, OH treated biofilm
bacteria appeared to be dehydrated with evident surface changes
(Figure 5D).
The antibiofilm effect of OH on A. baumannii can be
attributed to its binding to the negatively charged bacterial cell
envelope, thereby disrupting vital functions of the cell membrane
and killing the cell (Brill et al., 2006). It has a high affinity toward
cardiolipin, a prominent lipid in bacterial cell membranes,
making it selectively lethal to bacterial cells without adversely
affecting eukaryotic cells (Stewart and Costerton, 2001). In
addition, Al-Doori et al. (2007) reported that repeated exposure
of S. aureus to OH for up to 3 months did not induce resistance
to the compound. Therefore OH could be used as a potential
antimicrobial compound in controlling A. baumannii biofilms.
CONCLUSION
Results from the present study demonstrate the efficacy of OH
in rapidly inactivating A. baumannii biofilms on polystyrene,
stainless steel and urinary catheters in the presence and absence
of serum protein. Furthermore, the study demonstrates that OH
was equally effective in inactivating biofilms formed by multidrug
resistant and drug susceptible A. baumannii strains. These results
suggest that OH could be used as a sanitizer for hospital surfaces.
Additionally, sinceA. baumannii can form biofilms on indwelling
catheters, OH can be used as a potential antimicrobial lock
solution in catheters. However, further experiments are needed
to evaluate the stability and efficacy of OH in comparison with
other disinfectants, especially under hospital settings.
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